欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1486/001
药品名称
Lercatio
活性成分
lercanidipine hydrochloride 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Hexal A/S Edvard Thomsens Vej 14 2300 København S Denmark
参考成员国 - 产品名称
Denmark (DK)
Lercatio
互认成员国 - 产品名称
Belgium (BE)
Netherlands (NL)
Spain (ES)
Italy (IT)
Portugal (PT)
许可日期
2009/05/20
最近更新日期
2024/08/20
药物ATC编码
C08CA13 lercanidipine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
DK_H_1486_var 034 1_3_1_common_pl_002716167 cl
Date of last change:2022/06/02
Final SPC
|
DK_H_1486_var 034 1_3_1_common_spc_002716166 cl _1_
Date of last change:2022/06/02
Final Product Information
|
1.3.1_spc-label-pl_-_common-spc_-_11_2C447_clean
Date of last change:2020/07/03
Final Labelling
|
Label - DKH1486001-002P001 Lercatio, 61.3 notification, clean
Date of last change:2018/09/12
PAR
|
Final PAR_Modul 5 _Lercanidipine hydrochloride DKH1486
Date of last change:2010/01/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase